<DOC>
	<DOCNO>NCT02239627</DOCNO>
	<brief_summary>Low back pain common condition , affect majority adult United States point life . Fortunately , resolve , even without treatment . However , suffer continued recurrent pain . For suffer continued recurrent low back pain , numerous treatment option exist . One option epidural injection , particularly non-surgical treatment option fail . An epidural injection placement needle space around spinal cord aid live X-Ray machine , follow injection various medication . Typically , medication inject steroid , commonly combination local anesthetic medication . Epidural steroid injection , without local anesthetic part establish standard care United States continue recurrent low back pain . The steroid believe reduce inflammation edema injure irritated nerve . However , despite routine use epidural steroid , steroid without risk side effect . Though rare , steroid associate complication include osteoporosis , steroid induce myopathy , cataract many others . In order minimize side effect associate epidural steroid , limit dose frequency outline . Clonidine another medication , commonly use numerous clinical setting . U. S. Food Drug Administration approve medication epidural use cancer pain study show effectiveness non-cancer pain well routinely use various condition . There grow evidence use epidural clonidine treatment pain , include low back pain . This research study compare effectiveness , , clonidine compare steroid epidural injection low back pain .</brief_summary>
	<brief_title>Epidural Clonidine Versus Corticosteroid Low Back Pain</brief_title>
	<detailed_description />
	<mesh_term>Back Pain</mesh_term>
	<mesh_term>Low Back Pain</mesh_term>
	<mesh_term>Clonidine</mesh_term>
	<criteria>1 . Subject clinical diagnosis low back due intervertebral disc disease , spinal stenosis herniated disc 2 . Subject average pain score ( VAS ) least 5 3 . Subject persistent pain despite conservative care 4 . Subjects experience pain least 1 month 5 . 18 year age old write informed consent obtain 6 . Signed IRB approve informed consent form 1 . Allergy clonidine , dexamethasone , ropivicaine lidocaine 2 . Coagulopathy 3 . Active Infection 4 . Serious neurologic deficit 5 . Subject pregnant planning become pregnant course study 6 . Subject member vulnerable population 7 . Investigator suspect substance abuse might confound study result 8 . Subject unresolved major issue secondary gain ( determined investigator ) 9 . Subject exhibit major psychiatric morbidity , untreated refractory treatment determine investigator 10 . Currently diagnose cognitive impairment , exhibit characteristic , would limit study candidate 's ability ass pain relief complete study assessment</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2015</verification_date>
</DOC>